ReviewCancers2019
BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors.
Karisa C Schreck et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled ittrialcites it